Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9981944
GDF-8 inhibitors
granted -
US 9920041
Compositions and methods for inhibition of the JAK pathway
granted -
US 9913842
2,4-pyrimidinediamine compounds and their uses
granted -
US 9913843
Protein kinase C inhibitors and uses thereof
granted -
US 9890144
Compounds and method for treating autoimmune diseases
granted -
US 9884868
TGF-beta inhibitors
granted -
US 9878992
GDF-8 inhibitors
granted -
US 9845311
Nrf2 activating compounds and uses thereof
granted -
US 9845512
Screening assay employing Dex and GDF8
granted -
US 9834568
Kinase inhibitors and their uses
granted -
US 9751893
Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
granted -
US 9737554
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted -
US 9732073
Compositions and methods for inhibition of the JAK pathway
granted -
US 9732070
Protein kinase C inhibitors and uses thereof
granted -
US 9730930
Treatment for vitiligo
granted -
US 9725419
Cycloalkyl substituted pyrimidinediamine compounds and their uses
granted -
US 9701647
Tetrazolones as a carboxylic acid bioisosteres
granted -
US 9682976
Protein kinase C inhibitors and uses thereof
granted -
US 9663496
AMPK-activating heterocyclic compounds and methods for using the same
granted -
US 9650391
N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 9644224
Methods for cyclizing synthetic polymers
granted -
US 9624229
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
granted -
US 9611260
Compositions and methods for inhibition of the JAK pathway
granted -
US 9598432
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
granted